Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Purkinje cell pathology and loss in multiple sclerosis cerebellum.
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab.
Prevalence of stress urinary incontinence in women with multiple sclerosis.
Are there Epstein-Barr virus seronegative patients with multiple sclerosis?
Minocycline in Clinically Isolated Syndromes (CIS) and Early Single Relapse Multiple Sclerosis (MS)
Epitope spreading in immune-mediated diseases: implications for immunotherapy.
[HTLV-1-associated myelopathy/tropical spastic paraparesis : A differential diagnosis in multiple sclerosis.]
Mast Cell-Mediated Inhibition of Abdominal Neutrophil Inflammation by a PEGylated TLR7 Ligand.
Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis.
Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
Documenting outdoor activity and travel behaviour in persons with neurological conditions using travel diaries and GPS tracking technology: a pilot study in multiple sclerosis.
Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.
Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis.
Biologic therapies: lessons from multiple sclerosis.
White matter volume is decreased in the brain of patients with neuromyelitis optica.
Role of Platelets in Neurodegenerative Diseases: A Universal Pathophysiology.
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.
Plasma chemerin levels in patients with multiple sclerosis.
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.

Pages